Category
Ruxolitinib
CAS Number
1001070-45-6
Molecular Formula
C₁₂H₁₉N₃OSi
Molecular Weight
249.38 g/mol
Synonym

7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine; 7H-Pyrrolo[2,3-d]pyrimidine, 7-[[2-(trimethylsilyl)ethoxy]methyl]-; trimethyl-[2-(pyrrolo[2,3-d]pyrimidin-7-ylmethoxy)ethyl]silane

Keywords
Impurities
Impurities manufacturer and Suppliers in Hyderabad india
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Our Ruxolitinib Impurity B (CAS: 1001070-45-6; Formula: C₁₂H₁₉N₃OSi; MW: 249.38 g/mol and chemical name 7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine) is manufactured and supplied by Manasa Life Sciences in Hyderabad, India, to facilitate high-precision impurity profiling. We employ advanced HPLC, LCMS, NMR, and IR techniques under GMP/GDP compliance and strict EP, USP, USFDA, EMA, and ICH regulatory standards. Supported by an expert team of synthesis R&D and analytical R&D scientists, we provide an authoritative COA and MSDS that captures all critical chemical properties, ensuring you have the evidence needed for regulatory submissions. Our commitment to accuracy helps your laboratory resolve Impurity B from the parent compound with ease, supporting your verification of pharmaceutical quality. Partnering with Manasa Life Sciences means choosing a supplier that understands the complexities of pharmaceutical impurity standards and provides the high-integrity documentation required to achieve consistent, reproducible, and compliant research and manufacturing outcomes.